Covid-19 roundup: Ger­many sus­pends As­traZeneca vac­cine as British drug­mak­er de­fends shot amid blood clot scare

Fol­low­ing a raft of fel­low EU mem­bers sus­pend­ing use of the As­traZeneca/Ox­ford Covid-19 vac­cine, Ger­many has be­come the lat­est to pause dis­tri­b­u­tion of the shot.

The Ger­man gov­ern­ment said Mon­day it’s sus­pend­ing ad­min­is­tra­tion of the vac­cine af­ter re­ports of blood clots prompt­ed oth­er Eu­ro­pean na­tions to tem­porar­i­ly stop giv­ing the vac­cines to its cit­i­zens, the AP re­port­ed. As the de fac­to Eu­ro­pean eco­nom­ic pow­er­house, Ger­many be­comes the high­est-pro­file coun­try to en­dorse fur­ther in­ves­ti­ga­tion of the blood clot cas­es.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN